Literature DB >> 17691125

Enhanced surveillance of invasive meningococcal disease in Canada: 1 January, 2004, through 31 December, 2005.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17691125

Source DB:  PubMed          Journal:  Can Commun Dis Rep        ISSN: 1188-4169


× No keyword cloud information.
  9 in total

1.  Genetic and antigenic analysis of invasive serogroup C Neisseria meningitidis in Canada: A decrease in the electrophoretic type (ET)-15 clonal type and an increase in the proportion of isolates belonging to the ET-37 (but not ET-15) clonal type during the period from 2002 to 2009.

Authors:  Jianwei Zhou; Frances Jamieson; Sharon Dolman; Linda Mn Hoang; Prasad Rawte; Raymond Sw Tsang
Journal:  Can J Infect Dis Med Microbiol       Date:  2012       Impact factor: 2.471

2.  Epidemiology of invasive meningococcal disease with decreased susceptibility to penicillin in Ontario, Canada, 2000 to 2006.

Authors:  Elizabeth M Brown; David N Fisman; Steven J Drews; Sharon Dolman; Prasad Rawte; Shirley Brown; Frances Jamieson
Journal:  Antimicrob Agents Chemother       Date:  2010-01-19       Impact factor: 5.191

3.  Profile of serogroup Y meningococcal infections in Canada: Implications for vaccine selection.

Authors:  Nicole Le Saux; Julie A Bettinger; Susan Wootton; Scott A Halperin; Wendy Vaudry; David W Scheifele; Raymond Tsang
Journal:  Can J Infect Dis Med Microbiol       Date:  2009       Impact factor: 2.471

4.  A new meningococcal conjugate vaccine: What should physicians know and do?

Authors:  R Bortolussi; M Salvadori
Journal:  Paediatr Child Health       Date:  2009-10       Impact factor: 2.253

5.  Increase in ST-11 serogroup W Neisseria meningitidis invasive meningococcal disease in Canada, 2016-2018.

Authors:  R S Tsang; L Hoang; G J Tyrrell; J Minion; P Van Caeseele; J V Kus; B Lefebvre; D Haldane; R Garceau; G German; G Zahariadis; B Hanley
Journal:  Can Commun Dis Rep       Date:  2019-06-06

6.  Enhanced surveillance of invasive meningococcal disease in Canada, 2006-2011.

Authors:  Y A Li; R Tsang; S Desai; H Deehan
Journal:  Can Commun Dis Rep       Date:  2014-05-01

7.  Epidemiology of serogroup B invasive meningococcal disease in Ontario, Canada, 2000 to 2010.

Authors:  Vica Dang; Frances B Jamieson; Sarah Wilson; Prasad Rawte; Natasha S Crowcroft; Karen Johnson; Raymond S W Tsang; Shelley L Deeks
Journal:  BMC Infect Dis       Date:  2012-08-29       Impact factor: 3.090

8.  Characterization of invasive Neisseria meningitidis from Atlantic Canada, 2009 to 2013: With special reference to the nonpolysaccharide vaccine targets (PorA, factor H binding protein, Neisseria heparin-binding antigen and Neisseria adhesin A).

Authors:  Raymond Sw Tsang; Dennis Ks Law; Rita R Gad; Tim Mailman; Gregory German; Robert Needle
Journal:  Can J Infect Dis Med Microbiol       Date:  2015 Nov-Dec       Impact factor: 2.471

9.  Fast and accurate dynamic estimation of field effectiveness of meningococcal vaccines.

Authors:  Lorenzo Argante; Michele Tizzoni; Duccio Medini
Journal:  BMC Med       Date:  2016-06-30       Impact factor: 8.775

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.